Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
In the latest trading session, Progressive (PGR) closed at $274.67, marking a +0.78% move from the previous day.
Progressive (PGR) could produce exceptional returns because of its solid growth attributes.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
PGR seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.
In the closing of the recent trading day, Progressive (PGR) stood at $272.86, denoting a -0.64% change from the preceding trading day.
The Progressive (PGR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
In the latest trading session, Progressive (PGR) closed at $274.62, marking a +0.49% move from the previous day.
It is imperative to build a portfolio of low-beta stocks to navigate a volatile market. PGR, BIDU, TGNA & JD are well-poised to gain.
On Wednesday, investors felt that they couldn't make a lot of portfolio progress with Progressive (PGR -3.56%). The insurance company's stock was hit with a sell-off following an analyst's price target cut; on the back of this, it closed the day almost 4% down in price.
Zacks.com users have recently been watching Progressive (PGR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Progressive Corp reported strong Q4 and FY results, with a 21% increase in net written premiums and over 5 million new policies in 2024. The company is well-positioned for 2025, with improved pricing expected to support margin expansion and EPS growth, despite a slightly elevated valuation multiple. Risks include market saturation, potential recession impacts, and a slowdown in growth rates, which could affect investor expectations and valuation.